TrialTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

Efficacy of nimotuzumab plus gemcitabine usage as first-line treatment in patients with advanced pancreatic cancer.

Dan Su et al.PubMed ↗Publisher ↗

No numbers read from the abstract.